Ö. AŞKIN Et Al. , "Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic," DERMATOLOGIC THERAPY , vol.34, no.2, 2021
AŞKIN, Ö. Et Al. 2021. Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic. DERMATOLOGIC THERAPY , vol.34, no.2 .
AŞKIN, Ö., Ozkoca, D., UZUNÇAKMAK, T. K., & SERDAROĞLU, S., (2021). Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic. DERMATOLOGIC THERAPY , vol.34, no.2.
AŞKIN, Özge Et Al. "Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic," DERMATOLOGIC THERAPY , vol.34, no.2, 2021
AŞKIN, Özge Et Al. "Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic." DERMATOLOGIC THERAPY , vol.34, no.2, 2021
AŞKIN, Ö. Et Al. (2021) . "Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic." DERMATOLOGIC THERAPY , vol.34, no.2.
@article{article, author={Özge AŞKIN Et Al. }, title={Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic}, journal={DERMATOLOGIC THERAPY}, year=2021}